Lifecore Biomedical, Inc. operates as a contract development and manufacturing company. The Company offers sterile injectable pharmaceutical products in syringes and vials as well as the manufactures pharmaceutical-grade sodium hyaluronate. Lifecore Biomedical serves customers worldwide.

Current Report (Form 8-K | Period ending 2024-11-26)

Current Report (Form 8-K | Period ending 2024-11-21)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lifecore Biomedical (LFCR US)

Current Report (Form 8-K | Period ending 2024-11-26)

Current Report (Form 8-K | Period ending 2024-11-21)

Current Report (Form 8-K | Period ending 2024-11-07)

424B3 | Prospectus

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)